{"name":"Pharmatech","slug":"pharmatech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Trelstar","genericName":"Trelstar","slug":"trelstar","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Trelstar","genericName":"Trelstar","slug":"trelstar","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPU2p5OVl6UVhSRjNEaEU4aFlZU1dDTGNNZGppMG1mOE5IV2JWeVUzVGd3SXBGMkhvbzhtNmpPblBjSEk3T1dzRFFFY1Uyd2hmZkRCMkdzTWlPWkkwS3RQc3dtNkdvTzVvWVhRZHV2OU82VDFTX2lQR2NQOTZoU3VkakNCZW1jTkZ0OF95N2RLcGVQYjFSRUlSTnIzLUtKRUFYeE1MeTcyeGVOX0NH?oc=5","date":"2026-03-24","type":"pipeline","source":"Fierce Pharma","summary":"Wilmington PharmaTech commits $50M to US API expansion - Fierce Pharma","headline":"Wilmington PharmaTech commits $50M to US API expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNcWRFeDFObDBxeDdodHNkT1k0N2NnMkFraDN6SFFjc1RDZlB1VUpOeXdvNnRseGtFNlVKX3Q1cjBOX3MzdllLamU4bnVpTkpDQy0yMnZZbG82dkduN3JBVERXck40Y2RHdHJ1cXBfUi1acUNlVlJQTE5wNlExWlBqQzZER2RnNlhpcG5YaFZPYlpudnFtRkZLeGF6WG5pd05WdXpr?oc=5","date":"2026-03-24","type":"deal","source":"Nutritional Outlook","summary":"Pharma Tech Industries: Your Partner in Nutritional Excellence - Nutritional Outlook","headline":"Pharma Tech Industries: Your Partner in Nutritional Excellence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNbm9KUWp6SEJtMUxYYzg5RXlpYlJsY0xNZmVWZmg4UzBSNHFreGVObjlRTG9pSWFOaldsSFEzYVZOdEEtWV9iOTBXUVNseVJWRkZiM0FXSVQtSDBsaW5FZ3JPelRqaEFVY1UycllSR3ZlRlE5ZVZMci1xdnB5cy1LcGRJVTBGSUZWTEpvZjZLVTVXOExIMU0xV3hhQW50RGpjQ1RiMFdRMXh5UlY2TWgtY1NmeVpvNjg3ejdGekhyVQ?oc=5","date":"2026-03-13","type":"pipeline","source":"Markets Herald","summary":"From Health Tech to Fintech: Med X Pharma Tech’s $3.5 Billion Valuation Signals Expansion Strategy - Markets Herald","headline":"From Health Tech to Fintech: Med X Pharma Tech’s $3.5 Billion Valuation Signals Expansion Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPcml6YlBiU3RQOGI4MjJVSkY4Y1BpRUhtYkFYWHpjd3BDMlZCNW12Uk9veFk3V2NkeG05dkhWZXRvV1pnaHVfSVNVT3FxMk5nMHVBR21zNDcwY2U0dUZRaXc5QzR2Y0JsdEt2SEVkSl9IZ3dDM2pnSkczbEwtcUN6ZGR4aG5lbFp5WkI4M3M3bTFWWVh1T3hQbkp3?oc=5","date":"2026-01-16","type":"pipeline","source":"PharmTech.com","summary":"The Impact of Patient-Centric Formulations on Service Providers - PharmTech.com","headline":"The Impact of Patient-Centric Formulations on Service Providers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNX3E2YUtEbEtXcGpqc3VXVVFDMGpFTG1tOTBkTC1kS1FSaV94VmNraEFudWF6eXdoU1VLdXFfTTdPOGhZSGxDSl83RG1pMHlqWUNjVDNVNXF6Z0g0OEI4dXlXSTVKcHNaZG9GODBoNDJnRFRMZUJDNmlQSEJmSGdTOGo4dDN0cFpyZm1sOGRwTmhSV0c1c09FTzFlbjFGZ2h1VTNtStIBrAFBVV95cUxQa0NCSXZyZVNuSnNDRHhpSjhFQkp4NTM4WFA3MHJlTUFDT2hwMy1QUS16Z1RPY19jTjEyOE9NUWlUNXZmS1pxenU0bVoxM1hEQ2VOcS1seXhDU3NqNFRUclVKanZoMndWRmZmWXozTjdJSlZoSm9ZSVdXdEYyVFlCbWI1ek5NZzFxSVRrdjVBNXpDNXU5X2xrazV0X2FXWHNEMGlvUkdJQUJUWHVP?oc=5","date":"2025-12-18","type":"deal","source":"Delaware Business Times","summary":"Wilmington PharmaTech acquired by private equity group - Delaware Business Times","headline":"Wilmington PharmaTech acquired by private equity group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5qMFVERlNmV1o2bkV3ZXpXc0hqR1pYblZmX1plSFlhOS1yNXJRRDQ3bjFZMHNLZ0pZY2RJMlRad1l2WVlObnlnNUo0NkNxc21Bd3hpSXFta1B1MUNxVXdJU09Zbm80SGtERlFpeGh0Nk1UOHVD?oc=5","date":"2025-12-18","type":"pipeline","source":"Businesskorea","summary":"D&D Pharmatech Launches Radiotherapeutics Affiliate in the U.S. - Businesskorea","headline":"D&D Pharmatech Launches Radiotherapeutics Affiliate in the U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQbGxXUVZaLTdfUDBQVS1iNnVLWkZHalN1dS1OWDdfWU1DaFBHTks1RkpzdDBPT1VqQ0diQ3JxUVBCbkl0LVRzNU1QeEJjb2ZHWHVnWkFOTlhLYW5YRGZJa1d2LVhCSm9aN19nUmRDTENzWnZ1Y2dtWDdGTGRSdFFCWmxjRk9ZZVc5YU5mb0ExQ05NeVZIVE50RVI0OHU0QThG?oc=5","date":"2025-11-20","type":"patent","source":"BioWorld News","summary":"Hangzhou Baicreat Pharma-Tech patents new STAT6 inhibitors - BioWorld News","headline":"Hangzhou Baicreat Pharma-Tech patents new STAT6 inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPY2JIM0drcnlyd29SMlpwMmtmZjByT0NSYmpwZ25JTWJzLUtENlRKS3hkOUFIYmRITHNnZHNtb0VURXgtRjgzNkN3cHAtcWhZYldPZnRUMjNZT3BSbVMzcGFDMk8yYUhnSG00RVJQSVVNVFlwZVUzMmtDazZHanlaSzNqR01qak5Yb2RhbjdZa0pWWGtHTHo0NHM3VVliZw?oc=5","date":"2025-10-22","type":"pipeline","source":"Manufacturing Chemist","summary":"Wilmington PharmaTech secures further funding for its expansion from Curewell Capital - Manufacturing Chemist","headline":"Wilmington PharmaTech secures further funding for its expansion from Curewell Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPR1ZXbUxuLTVwdjFNMWc5VnRsUk81aTQxa2ZwMnk1dm14NVMwMHdYbWcyWXV2QmdJWXBTdldhQld0djRaS3VTRVVZTXMySVZ3T0phWjNMMzJ5VHVQdVRBb0ZVU0VZZ1JuQTcxalpyQWdiWkVYYzIzb0NHcUNnZWx2b0VDMWpTV0JvWXYtTlppbUY1VGFQcWxWNXphNW45TlVRYWs5QjNDMGpHeDR4S3ZERTkxTnhmYTNpQS1NaEdDc2o1bVk2dVJMaDM4VFJwMTR4T2g0X3MzVS01a3pTVTM0U2V3?oc=5","date":"2025-10-21","type":"pipeline","source":"Business Wire","summary":"Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital - Business Wire","headline":"Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9OeXlrNmtGcDFpRE5uTU5MYVZkOWFlY09WN2hxRDRTQTZVcDdibGVfVUFydFdSc0NxNTUxSDhUM0E0NEhrRWdLWXNOZVE1VG1SekdxYzc3SVdIUmJrOGdoMEJoRGVOdXRDV05YZ0xFLXlndw?oc=5","date":"2025-10-21","type":"pipeline","source":"pehub.com","summary":"Curewell invests in Wilmington PharmaTech - pehub.com","headline":"Curewell invests in Wilmington PharmaTech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9oeUFxNWVlT25EZm9Wd2hERzcyaDFrTmVoVDVkTE1lV3k3aVlPdnRBc3puNF9DTXRDdUhKY2tVdThtejJwNnJJMVU4OFRWYzRBM2JXaElYX0c1V2JCc0J2R1BxcTlzazhCZXdJVDJwVWVOS2JvYk1FWGh4QQ?oc=5","date":"2025-07-22","type":"pipeline","source":"Yahoo Finance","summary":"Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as Company Prepares Public Launch - Yahoo Finance","headline":"Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as Company Prepares Public Launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxQMWZPY1dkVlMwczVxY2o2RThwRWZHNmtKNkk3ZnpvOWltMmpIX2hnZnAtdDZHemNPWnROcUJvMXZzNTZUQ09KeDkxVWMtYkpDOXFJWjJweEZiak5oNmVRVTBCSkpCOHFOQnpNc280VDU2LWJXT0M2TDFaTVlOSXE0T1EzR1ZQVTgwV1lEcDNROUpxWklzN19mVFFTWEJqekJwQ0NDbUp3RDBQRUJaWWlmcm5rdDY4cm1va0FUR3otX3IyWUdGcjFBLXRTSGVERGZBcjI0QzZ0RzZQaWZ2cE5kWDE3VU95ckUzN0lNaEtaWlNrNjY0WFJSalJJRjZscm9PeFE?oc=5","date":"2025-06-20","type":"pipeline","source":"ksdk.com","summary":"Contract drug manufacturer to close Franklin County plant, lay off dozens - ksdk.com","headline":"Contract drug manufacturer to close Franklin County plant, lay off dozens","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}